Canada Markets close in 5 hrs 29 mins
  • S&P/TSX

    21,184.81
    -89.76 (-0.42%)
     
  • S&P 500

    4,578.80
    +1.69 (+0.04%)
     
  • DOW

    35,276.51
    -91.96 (-0.26%)
     
  • CAD/USD

    0.7999
    +0.0004 (+0.0472%)
     
  • CRUDE OIL

    86.37
    +0.94 (+1.10%)
     
  • BTC-CAD

    52,854.18
    +377.70 (+0.72%)
     
  • CMC Crypto 200

    1,003.58
    +8.83 (+0.89%)
     
  • GOLD FUTURES

    1,837.00
    +24.60 (+1.36%)
     
  • RUSSELL 2000

    2,099.84
    +3.62 (+0.17%)
     
  • 10-Yr Bond

    1.8490
    -0.0160 (-0.86%)
     
  • NASDAQ

    14,573.17
    +66.27 (+0.46%)
     
  • VOLATILITY

    22.61
    -0.18 (-0.79%)
     
  • FTSE

    7,594.11
    +30.56 (+0.40%)
     
  • NIKKEI 225

    27,467.23
    -790.02 (-2.80%)
     
  • CAD/EUR

    0.7048
    -0.0006 (-0.09%)
     

Paige Founder and Cancer Pathology Thought Leader Dr. David Klimstra Featured on the Impact Podcast with John Shegerian

·2 min read

LOS ANGELES, December 07, 2021--(BUSINESS WIRE)--David Klimstra MD, Founder and Chief Medical Officer at Paige, the first company to receive FDA approval for an AI product in digital pathology, Paige Prostate, is a featured guest on the Impact Podcast with John Shegerian this week. The show is hosted by Shegerian, Co-Founder and Executive Chairman of ERI, the nation’s leading fully integrated IT and electronics asset disposition provider and cybersecurity-focused hardware destruction company.

Dr. Klimstra also serves as Medical Consultant at Memorial Sloan Kettering Cancer Center and Professor of Pathology and Laboratory Medicine at Weill Medical College of Cornell University. An internationally recognized expert on the pathology of tumors of the digestive system, pancreas, liver, and neuroendocrine system, he has published over 425 primary articles and his research focuses on the correlation of morphological and immunohistochemical features of tumors of the gastrointestinal tract, liver, biliary tree, and (most notably) pancreas with their clinical and molecular characteristics.

Dr. Klimstra received his M.D. and completed a residency in anatomic pathology at Yale University, and he completed fellowship training in oncologic surgical pathology at Memorial Sloan Kettering Cancer Center.

"It was an honor to have Dr. Klimstra on our show to tell his story and share the incredible work he and Paige are doing to harness AI technology for health diagnostics and the treatment of cancer," said Shegerian. "I’m sure our audience will be inspired and fascinated to learn about these game-changing innovations."

Every week, Impact Podcast guests are invited as thought leaders to share with listeners first-hand accounts of how they are able to make the world a better place on a daily basis.

Recent guests have included leaders from Verizon, Best Buy, General Motors, Unilever, Procter & Gamble, Johnson & Johnson, JetBlue, Comerica Bank, Goodyear Tire, Virgin, Dell, GE, IBM, Qualcomm, Ben & Jerry’s, Timberland, The Hershey Company, Nestle Waters, FedEx, Intel, New York City, Beyond Meat, Lipton Tea, Patron Tequila, Dell, Panasonic, Molson Coors, Seventh Generation, the NBA, the US Tennis Association, Waste Management, the Ellen MacArthur Foundation, and a number of fascinating thought leaders and game-changers, including Martin Luther King III; best-selling author Ryan Holiday; real estate powerhouse and television personality Ryan Serhant; writer/comedian/author Jeannie Gaffigan; softball legend and ESPN baseball anchor Jessica Mendoza; PTSD treatment pioneer, Dr. Rick Doblin; ESPN radio personalities Sarah Spain and Israel Gutierrez; ultra-endurance athlete Rich Roll; the late, legendary actor Ed Asner; and hundreds more.

The Impact Podcast with John Shegerian is available for listening on ImpactPodcast.com, Apple’s iTunes, Amazon Music, Google Podcasts, Spotify, libsyn, and as part of iHeartRadio’s digital broadcast, reaching over 120 million users.

To book a guest on the show, contact producer Linda Ramos at Linda.Ramos@impactpodcast.com.

For more information, visit ImpactPodcast.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20211207006180/en/

Contacts

Paul Williams, 310/569-0023, paul.williams@eridirect.com

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting